“Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)” (2020) SKIN The Journal of Cutaneous Medicine, 4(5), p. s44. doi:10.25251/skin.4.supp.44.